Evidence map›Paper›PMID 42564981›Full record

ArticleMolecular therapy. Advances2026

Natural killer cell cryopreservation: Influence of composition, temperature, and granules on post-thaw survival and function.

Adam Joules, Troy Louwagie, Akshat S Mallya, Allison Hubel

Abstract read
In one paragraph

Article in Molecular therapy. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adam JoulesDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
Troy LouwagieDepartment of Mechanical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
Akshat S MallyaDepartment of Mechanical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
Allison HubelDepartment of Mechanical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cells are promising off-the-shelf cancer immunotherapies, but their scalable deployment requires effective cryopreservation. Conventional dimethyl sulfoxide (DMSO)-based methods are associated with toxicity and persistent post-thaw functional impairment, and the mechanisms underlying NK cell cryoinjury remain incompletely understood. We investigated NK cell dysfunction following cryopreservation and evaluated DMSO-free cryoprotectant formulations as alternative strategies. DMSO-free formulations were optimized using a differential evolution algorithm. Cryopreserved NK-92 cells were assessed post-thaw for viability, recovery, proliferation, and cytotoxicity over 5 days. Raman cryomicroscopy and flow cytometry were used to characterize cytolytic granule localization and integrity during cooling and freezing. Pre-freezing chemical degranulation was performed to probe granule-mediated injury. Both DMSO-based and DMSO-free formulations had immediate post-thaw recovery and viability over 80% but had notable cell loss over 24 h. Although proliferation resumed by 48 h, expansion remained attenuated, and cytotoxic function was reduced by ≥ 20% and did not recover after 3-5 days. Imaging revealed temperature- and cryoprotective agent (CPA)-induced granule redistribution and destabilization. Pre-freeze degranulation improved short-term recovery and proliferation. These findings support cytolytic granule redistribution and destabilization as contributors to persistent NK cell dysfunction and may inform future cryopreservation strategies for NK cell therapies.

Indexed as

cell therapycryopreservationdifferential evolutionDMSO-freenatural killerRaman

Identifiers

PMID42564981
PMCPMC13446314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.